<?xml version="1.0" encoding="UTF-8"?>
<ref id="B169-vaccines-08-00036">
 <label>169.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Pollard</surname>
    <given-names>S.R.</given-names>
   </name>
   <name>
    <surname>Dunn</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Cammack</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>Minor</surname>
    <given-names>P.D.</given-names>
   </name>
   <name>
    <surname>Almond</surname>
    <given-names>J.W.</given-names>
   </name>
  </person-group>
  <article-title>Nucleotide sequence of a neurovirulent variant of the type 2 oral poliovirus vaccine</article-title>
  <source>J. Virol.</source>
  <year>1989</year>
  <volume>63</volume>
  <fpage>4949</fpage>
  <pub-id pub-id-type="doi">10.1128/JVI.63.11.4949-4951.1989</pub-id>
  <?supplied-pmid 2552175?>
  <pub-id pub-id-type="pmid">2552175</pub-id>
 </element-citation>
</ref>
